Second Quarter 2025 Earnings July 16, 2025 Disclaimers Non-GAAP Information Certain measures included in this document are "non-GAAP," meaning they are not presented in accordance with generally accepted accounting principles in the U.S. and also are not codified in U.S. banking regulations currently applicable to FHN. Although other entities may use calculation methods that differ from those used by FHN for non-GAAP measures, FHN's management believes such measures are relevant to understanding the financi ...

Business Update July 16, 2025 2 Disclaimer Certain information in this presentation and discussed on the conference call which this presentation accompanies constitutes forward -looking information within the meaning of the Private Securities Litigation Reform Act of 1995 . Statements in this presentation regarding the Company's business that are not historical facts are "forward -looking statements" that involve risks and uncertainties and are based on current expectations and management estimates ; actual ...

Consolidated Financial Performance - Net revenues for the second quarter of 2025 were $16792 million, a decrease of 5% from the first quarter of 2025 but an increase of 12% from the second quarter of 2024[2] - Net income applicable to Morgan Stanley for the second quarter of 2025 was $3539 million, a decrease of 18% from the first quarter of 2025 but an increase of 15% from the second quarter of 2024[2] - Earnings applicable to Morgan Stanley common shareholders for the second quarter of 2025 were $3392 million, a decrease of 18% from the first quarter of 2025 but an increase of 15% from the second quarter of 2024[2] - For the six months ended June 30, 2025, net revenues were $34531 million, a 15% increase compared to $30155 million for the six months ended June 30, 2024[2] - For the six months ended June 30, 2025, earnings applicable to Morgan Stanley common shareholders were $7549 million, a 22% increase compared to $6208 million for the six months ended June 30, 2024[2] Segment Performance - Institutional Securities net revenues for the second quarter of 2025 were $7643 million, a decrease of 15% from the first quarter of 2025 but an increase of 9% from the second quarter of 2024[2] - Wealth Management net revenues for the second quarter of 2025 were $7764 million, an increase of 6% from the first quarter of 2025 and a 14% increase from the second quarter of 2024[2] - Investment Management net revenues for the second quarter of 2025 were $1552 million, a decrease of 3% from the first quarter of 2025 but an increase of 12% from the second quarter of 2024[2] Balance Sheet and Capital - Total assets as of June 30, 2025, were $1353870 million, a 4% increase from March 31, 2025, and a 12% increase from June 30, 2024[5] - Total loans as of June 30, 2025, were $267395 million, a 3% increase from March 31, 2025, and a 12% increase from June 30, 2024[5] - Common equity as of June 30, 2025, was $98434 million, a 1% increase from March 31, 2025, and a 7% increase from June 30, 2024[5]

Net Income Available to Common Shareholders of $233 Million with an EPS of $0.45, a $0.04 Increase from Prior Quarter; $229 Million or $0.45 on an Adjusted Basis, up $0.03 from Prior Quarter* MEMPHIS, Tenn., July 16, 2025 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN or "First Horizon") today reported second quarter net income available to common shareholders ("NIAC") of $233 million or earnings per share of $0.45, compared with first quarter 2025 NIAC of $213 million or earnings per share of $0.41. ...

Financial Performance - Fly-E Group, Inc. reported net revenues of $25.4 million for fiscal year 2025, a decrease of 21.0% from $32.2 million in fiscal year 2024, primarily due to a reduction in sales volume by 10,846 units [4][5] - Retail sales revenue was $21.7 million, down 17.7% from $26.4 million in fiscal year 2024, while wholesale revenue decreased by 39.3% to $3.5 million [5] - The company experienced a net loss of $5.3 million in fiscal year 2025, compared to a net income of $1.9 million in fiscal year 2024, with basic and diluted losses per share of $1.10 [8][12][11] Cost and Profitability - Cost of revenues decreased to $15.0 million, down 21.6% from $19.1 million in fiscal year 2024, attributed to favorable pricing from suppliers and reduced sales volume [6] - Gross profit was $10.5 million, a decrease of 20.3% from $13.1 million in fiscal year 2024, with a gross margin of 41.1%, slightly up from 40.7% in the previous year [9][8] Operating Expenses - Operating expenses increased by 52.5% to $15.0 million, driven by higher payroll, rent, professional fees, and product development costs [10] - Selling expenses rose to $7.4 million, while general and administrative expenses increased to $7.6 million, reflecting the company's expansion efforts and increased operational costs [15] Cash Flow and Financial Condition - As of March 31, 2025, the company had cash of $0.8 million, down from $1.4 million a year earlier, with net cash used in operating activities amounting to $10.1 million [14] - Net cash provided by financing activities was $12.5 million, compared to a slight outflow of $0.05 million in fiscal year 2024, indicating improved capital raising efforts [16] Strategic Outlook - The company aims to enhance product safety, expand geographic reach, and invest in digital platforms to improve customer experience, following a successful public offering in June 2025 [3] - Fly-E has diversified its product portfolio to over 100 models and is expanding its rental services, which are currently operational in major cities like New York, Toronto, and Los Angeles [3]

Financial Performance - Net income was $113.5 million, or $1.32 per diluted share, compared to $119.5 million, or $1.38 per diluted share in 1Q25[24, 25] - Adjusted Pre-Provision Net Revenue (PPNR) totaled $167.9 million, up $5.5 million compared to 1Q25[24, 25] - Net Interest Margin (NIM) was 3.49%, up 6 bps compared to 1Q25[24, 25] - Efficiency ratio was 54.91%, improved 31 bps compared to prior quarter[24, 25] Balance Sheet - Total assets reached $35.2 billion[10] - Loans totaled $23.5 billion, up $364 million, or 6% LQA[10, 25, 29] - Deposits totaled $29.0 billion, down $148 million, or 2% LQA[10, 25, 36] - CET1 ratio was estimated at 14.03%, down 45 bps linked-quarter; TCE ratio at 9.84%, down 17 bps linked-quarter[10, 24, 25] Asset Quality - Criticized commercial loans totaled $569 million, or 3.15% of total commercial loans, down $25 million from $594 million, or 3.35% of total commercial loans, in prior quarter[38, 39] - Nonaccrual loans totaled $95 million, or 0.40% of total loans, down $9 million from $104 million, or 0.45% of total loans, in prior quarter[38, 39] - ACL coverage solid at 1.45%, compared to 1.49% in prior quarter[25, 41] Forward Guidance - Expect EOP loans at 12/31/25 to be up low single digits from 12/31/24 levels[74] - Expect NII (te) to be up between 3%-4% from FY24; expect modest NIM expansion throughout 2H25[74] - Expect noninterest income to be up 9%-10% from FY24 noninterest income[74]

Financial Performance - Q2 2025 organic revenue grew by 30%[9] - Q2 Non-GAAP Adj EBITA increased by 41% to $6138 million with a 153% margin[10] - Q2 Non-GAAP adjusted diluted EPS increased by 51% to $205[10] - The company repurchased $142 million in shares in Q2 and $223 million year-to-date[10] Revenue Breakdown - Media & Advertising and Precision Marketing accounted for 68% of total revenue with combined organic growth exceeding 7%[9] - Total revenue for the second quarter was $40156 million a 42% increase[11] - Year-to-date revenue reached $77060 million a 30% increase[11] Strategic Initiatives - The Interpublic (IPG) Transaction cleared antitrust review by the US Federal Trade Commission in late June 2025 with closing expected in the second half of 2025[9] - The company achieved a $250 million year-to-date improvement in the use of operating capital[10]

Core Insights - Kestra Medical Technologies, Ltd. reported strong financial results for Q4 and FY25, driven by increased demand for its ASSURE® cardiac recovery system [3][5][6] - The company achieved a total revenue of $59.8 million in FY25, marking a 115% increase compared to FY24 [5][6] - Gross margin improved significantly, reaching 44.3% in Q4 FY25 and 40.5% for FY25, compared to 13.9% and 1.3% in the prior periods respectively [6][15] Financial Performance - Q4 FY25 revenue was $17.2 million, a 71% increase year-over-year, with 3,903 prescriptions written for the ASSURE® system, up 43% from the previous year [6][7] - The company generated a gross profit of $7.6 million in Q4 FY25, compared to $1.4 million in the same period last year [7][20] - GAAP net loss for Q4 FY25 was $51.1 million, compared to a loss of $22.3 million in Q4 FY24 [7][21] Operational Highlights - The company wrote a total of 13,193 prescriptions for the ASSURE® system in FY25, a 72% increase from FY24 [15] - Operating expenses for FY25 were $130.6 million, up from $85.4 million in FY24, largely due to increased commercial and revenue cycle resources [15][21] - Cash and cash equivalents stood at $237.6 million as of April 30, 2025, a significant increase from $8.2 million a year earlier [18] Future Outlook - Kestra has initiated revenue guidance for FY26 at $85 million, representing a 42% increase compared to FY25 [6][9] - The company remains focused on innovation and enhancing prescriber and patient support to drive market expansion [3][6]

Financial Performance - Total revenue reached $3.4 billion, an increase of 8%, or 9% excluding notable items[4] - Fee revenue totaled $2.7 billion, up 11%, or 12% excluding notable items[4] - Expenses amounted to $2.5 billion, reflecting an 11% increase, or 6% excluding notable items[4] - EPS reached $2.17, up 1%, or $2.53, up 18% excluding notable items[4] Business Momentum - Record AUC/A of $49.0 trillion at quarter-end, with AUC/A wins of $1093 billion[4] - New servicing fee revenue wins of $145 million primarily related to back office[4] - Record AUM of $5.1 trillion at quarter-end with total net inflows of $82 billion, including record Institutional net inflows of $68 billion[4] - FX trading volumes increased by 17%[4] Capital Allocation - Returned $517 million to common shareholders, including $300 million in share repurchases and $217 million in declared dividends[4] - Announced a planned 11% increase to 3Q25 per share quarterly common stock dividend to $0.84, subject to Board approval[4]

Financial Performance - Equity Bancshares reported core net income of $175 million for Q2 2025[21] - Core earnings per share reached $099 in Q2 2025[21] - The company's net interest margin stood at 417% for Q2 2025[22] - Return on average tangible common equity (ROATCE) was 1264% for Q2 2025[22] - Tangible book value per share increased to $3217 in Q2 2025[6, 18, 19] Balance Sheet - Total assets amounted to $54 billion[6] - Gross loans totaled $36 billion[6, 21] - Total deposits reached $42 billion[6, 21] - The loan to deposit ratio was 850%[54] Capital Management - The company's TCE/TA ratio was 1063%[6] - CET 1 Capital Ratio was 1507%[6] - Total Risk-based Capital Ratio was 1684%[6]